Gland Pharma Limited (NSE:GLAND)
1,619.00
+14.15 (0.88%)
Mar 28, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 262.36 billion as of March 31, 2025. Its market cap has decreased by -9.12% in one year.
Market Cap
262.36B
Enterprise Value
237.42B
Revenue
57.29B
Ranking
n/a
PE Ratio
37.24
Stock Price
1,619.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 262.36B, a decrease of -11.69%. That is a compound annual growth rate of -2.82%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 262.36B | -10.50% |
Dec 31, 2024 | 293.15B | -7.51% |
Dec 29, 2023 | 316.97B | 22.08% |
Dec 30, 2022 | 259.64B | -59.11% |
Dec 31, 2021 | 634.96B | 66.20% |
Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4,162.13B |
Divi's Laboratories | 1,533.20B |
Cipla | 1,164.75B |
Mankind Pharma | 1,000.40B |
Apollo Hospitals Enterprise | 951.31B |
Zydus Lifesciences | 891.93B |
Aurobindo Pharma | 674.02B |
Alkem Laboratories | 583.68B |